Search Results - Seth M. Pollack
- Showing 1 - 14 results of 14
-
1
-
2
-
3
Durable response to treatment of an atypical desmoplastic small round cell tumor with enfortumab-vedotin by John S. Wang, Jack C. Shapiro, Sarah Orlando, Rusul Al-Marayaty, Farres Obeidin, David VanderWeele, Haris Charalambous, Seth M. Pollack, Pedro Hermida de Viveiros
Published in Journal of Cancer Research and Clinical Oncology (2025-02-01)Get full text
Article -
4
Durable disease regression with copanlisib treatment in PI3K-mutated metastasizing ameloblastoma: A case report by Meghan M Lynch, Pedro Hermida-Viveiros, Sean Stencel, Hannah Knott, Rusul Al-Maryati, Farres Obeidin, Borislav A Alexiev, Susan Abbinanti, Senthil Damodaran, Mark Agulnik, Seth M Pollack
Published in Rare Tumors (2025-12-01)Get full text
Article -
5
Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapy by Cassian Yee, Seth M Pollack, Robin L Jones, Jianhong Cao, Ernest U Conrad, Stanley R Riddell, Brett A Schroeder, Ralph Graeme Black, Sydney Spadinger, Shihong Zhang, Karan Kohli, Jose G Mantilla
Published in Journal for ImmunoTherapy of Cancer (2020-05-01)Get full text
Article -
6
Generation of effective and specific human TCRs against tumor/testis antigen NY-ESO-1 in mice with humanized T cell recognition system by Xiaojing Tina Chen, Xiaojing Tina Chen, Matthias Leisegang, Matthias Leisegang, Ioannis Gavvovidis, Ioannis Gavvovidis, Seth M. Pollack, Felix K. M. Lorenz, Ton N. Schumacher, Ton N. Schumacher, Oliver Daumke, Thomas Blankenstein
Published in Frontiers in Immunology (2024-12-01)Get full text
Article -
7
Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment. by Kendall C Shibuya, Vikas K Goel, Wei Xiong, Jonathan G Sham, Seth M Pollack, Allison M Leahy, Samuel H Whiting, Matthew M Yeh, Cassian Yee, Stanley R Riddell, Venu G Pillarisetty
Published in PLoS ONE (2014-01-01)Get full text
Article -
8
Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC‐3G3) to patients with advanced soft tissue sarcoma by Victor M. Villalobos, Gary Mo, Mark Agulnik, Seth M. Pollack, Daniel A. Rushing, Arun Singh, Brian A. Van Tine, Rhian McNaughton, Rodney L. Decker, Wei Zhang, Ashwin Shahir, Damien M. Cronier
Published in Cancer Medicine (2020-02-01)Get full text
Article -
9
Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States by Seth M. Pollack, Neeta Somaiah, Dejka M. Araujo, Mihaela Druta, Brian A. Van Tine, Melissa A. Burgess, Sant P. Chawla, Mahesh Seetharam, Scott H. Okuno, Chet Bohac, Michael Chen, Sergey Yurasov, Steven Attia
Published in Cancer Medicine (2020-07-01)Get full text
Article -
10
Primary Management of Localized Gastrointestinal Stromal Tumors With Imatinib Monotherapy: An Alternative to Resection of Patients Precluded From Surgery by John S Wang, Brandon L Ellsworth, Rusul Al-Marayaty, Sean Stencel, Farres Obeidin, Borislav A Alexiev, Akhil Chawla, Jeffrey D Wayne, Vinai Gondi, John Hayes, Fahad Faruqi, Seth M Pollack, Pedro Hermida de Viveiros
Published in Clinical Medicine Insights: Oncology (2025-06-01)Get full text
Article -
11
B7-H3 is widely expressed in soft tissue sarcomas by Meghan M. Lynch, Rusul Al-Marayaty, Farres Obeidin, Borislav A. Alexiev, Eleanor Y. Chen, Pedro Viveiros, Brett A. Schroeder, Kelly Hudkins, Timothy M. Fan, Mary W. Redman, Kelsey K. Baker, George Jour, Lee D. Cranmer, Seth M. Pollack
Published in BMC Cancer (2024-10-01)Get full text
Article -
12
DNA demethylating agents suppress preclinical models of synovial sarcoma by Nobuhiko Hasegawa, Nezha S. Benabdallah, Kyllie Smith-Fry, Li Li, Sarah McCollum, Jinxiu Li, Caelen A. Jones, Lena Wagner, Vineet Dalal, Viola Golde, Anastasija Pejkovska, Lara Carroll, Malay Haldar, Seth M. Pollack, Scott W. Lowe, Torsten O. Nielsen, Ana Banito, Kevin B. Jones
Published in The Journal of Clinical Investigation (2025-07-01)Get full text
Article -
13
MRI Radiomic Features Are Independently Associated With Overall Survival in Soft Tissue Sarcoma by Matthew B. Spraker, MD, PhD, Landon S. Wootton, PhD, Daniel S. Hippe, MS, Kevin C. Ball, MD, Jan C. Peeken, MD, Meghan W. Macomber, MD, Tobias R. Chapman, MD, Michael N. Hoff, PhD, Edward Y. Kim, MD, Seth M. Pollack, MD, Stephanie E. Combs, MD, Matthew J. Nyflot, PhD
Published in Advances in Radiation Oncology (2019-04-01)Get full text
Article -
14
Early, precise, and safe clinical evaluation of the pharmacodynamic effects of novel agents in the intact human tumor microenvironment by Kenneth R. Gundle, Kenneth R. Gundle, Karthik Rajasekaran, Jeffrey Houlton, Gary B. Deutsch, Thomas J. Ow, Thomas J. Ow, Robert G. Maki, Robert G. Maki, John Pang, Cherie-Ann O. Nathan, Daniel Clayburgh, Daniel Clayburgh, Jason G. Newman, Elyse Brinkmann, Michael J. Wagner, Seth M. Pollack, Seth M. Pollack, Matthew J. Thompson, Ryan J. Li, Vikas Mehta, Bradley A. Schiff, Barry I. Wenig, Paul L. Swiecicki, Alice L. Tang, Jessica L. Davis, Annemieke van Zante, Jessica A. Bertout, Wendy Jenkins, Atticus Turner, Marc Grenley, Connor Burns, Jason P. Frazier, Angela Merrell, Kimberly H. W. Sottero, Jonathan M. J. Derry, Kate C. Gillespie, Bre Mills, Richard A. Klinghoffer
Published in Frontiers in Pharmacology (2024-04-01)Get full text
Article
